Combined Tyrosine and Serine/Threonine Kinase Inhibition by Sorafenib Prevents Progression of Experimental Pulmonary Hypertension and Myocardial Remodeling-Reference-Cited by-同舟云学术

Combined Tyrosine and Serine/Threonine Kinase Inhibition by Sorafenib Prevents Progression of Experimental Pulmonary Hypertension and Myocardial Remodeling

Published:2008-11-11 Issue:20 Volume:118 Page:2081-2090
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Klein Martina¹,Schermuly Ralph T.¹,Ellinghaus Peter¹,Milting Hendrik¹,Riedl Bernd¹,Nikolova Sevdalina¹,Pullamsetti Soni S.¹,Weissmann Norbert¹,Dony Eva¹,Savai Rajkumar¹,Ghofrani Hossein A.¹,Grimminger Friedrich¹,Busch Andreas E.¹,Schäfer Stefan¹

Affiliation:

1. From Cardiology Research, Bayer Schering Pharma, Wuppertal (M.K., B.R., A.E.B., S.S.); Max-Planck Institute for Heart and Lung Research, Bad Nauheim (R.T.S.); University of Giessen Lung Center, Giessen (R.T.S., S.N., S.S.P., N.W., E.D., R.S., H.A.G., F.G.); Target Discovery, Bayer Schering Pharma, Wuppertal (P.E.); and Heart and Diabetes Center NRW, Bad Oeynhausen (H.M.), Germany.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference38 articles.

1. Cellular and molecular pathobiology of pulmonary arterial hypertension

2. Reversal of experimental pulmonary hypertension by PDGF inhibition

3. Fibroblast Growth Factor-2 Expression Is Altered in Lambs With Increased Pulmonary Blood Flow and Pulmonary Hypertension

4. Epidermal Growth Factor Receptor Blockade Mediates Smooth Muscle Cell Apoptosis and Improves Survival in Rats With Pulmonary Hypertension

Cited by 133 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Landscape of molecular crosstalk between SARS-CoV-2 infection and cardiovascular diseases: emphasis on mitochondrial dysfunction and immune-inflammation;Journal of Translational Medicine;2023-12-16

2. Inhaled nintentanib, pirfenidone and macitentan for pulmonary fibrosis: a laboratory experiment;Therapeutic Delivery;2023-08

3. Pathophysiological Involvement of Mast Cells and the Lipid Mediators in Pulmonary Vascular Remodeling;International Journal of Molecular Sciences;2023-04-01

4. New Drugs and Therapies in Pulmonary Arterial Hypertension;International Journal of Molecular Sciences;2023-03-19

5. Pathophysiology and new advances in pulmonary hypertension;BMJ Medicine;2023-03